Cypherpunk Technologies is doubling down on privacy by expanding its Zcash holdings, positioning itself as a major force within the privacy coin’s ecosystem.
Quick Summary – TLDR:
- Cypherpunk Technologies acquired 56,418 ZEC for $29 million, bringing total holdings to over 290,000 ZEC.
- The company now controls approximately 1.76% of Zcash’s circulating supply.
- Average purchase price sits at $334.41 per ZEC, indicating long-term strategic accumulation.
- Cypherpunk’s goal is to own 5% of the Zcash network, reflecting strong conviction in privacy tech.
What Happened?
Cypherpunk Technologies Inc. recently purchased 56,418.09 Zcash (ZEC) at an average price of $514.02 per token, amounting to a $29 million investment. With this move, the company’s total ZEC holdings have increased to 290,062.67, which equals around 1.76% of the circulating supply. This bold acquisition fits into Cypherpunk’s broader strategy of building a crypto treasury anchored in privacy-focused assets.
Cypherpunk has accumulated an additional 56,418 ZEC for $29 million at an average price of ~$514 per ZEC.
— Cypherpunk (@cypherpunk) December 30, 2025
As of 12/30/25, we ZODL ~1.76% of the network.
Onward. pic.twitter.com/yxireum4yr
Cypherpunk’s Long Bet on Privacy
Cypherpunk has made it clear that Zcash isn’t just another asset on its books. The company views financial privacy as a long-term strategic asset and Zcash as a key infrastructure component rather than a speculative token. Unlike many firms diversifying into a mix of digital assets, Cypherpunk is placing its bet squarely on Zcash.
- Zcash allows for shielded transactions, which can obscure sender and receiver identities, along with the amount being transferred.
- The company’s cumulative average acquisition price is $334.41 per ZEC, suggesting a methodical, long-term build-up over various market cycles.
- This strategy marks a sharp contrast to firms that chase crypto market trends or treat digital assets purely as tradeable commodities.
Will McEvoy, CIO of Cypherpunk said:
Dual Identity: Crypto Meets Cancer Research
Cypherpunk is not your typical crypto firm. While it has become a major player in privacy-focused digital assets, the company also holds a stake in the healthcare sector through its subsidiary, Leap Therapeutics.
- Leap Therapeutics is involved in developing cancer therapies, including clinical-stage drugs like sirexatamab and FL-501.
- This makes Cypherpunk unique: it operates at the intersection of privacy tech and biotech, two fields with very different timelines and risk profiles.
The company says it will continue to report material updates through regulatory filings and investor channels as it builds shareholder value across both domains.
Why This Move Matters?
This latest ZEC purchase sends a strong message to the market. In an era where privacy debates are becoming increasingly intense from digital surveillance to financial transparency, Cypherpunk is making a focused, high-conviction play.
- With 1.76% of Zcash already under its control, the firm is setting a new bar for crypto treasury strategies.
- By publicly stating its 5% ownership target, Cypherpunk is signaling long-term alignment with the Zcash ecosystem.
- The strategy reflects a belief that privacy will remain a scarce and valuable commodity in the digital economy.
SQ Magazine’s Takeaway
I love how Cypherpunk is not just investing in crypto like everyone else but is instead making a deliberate, unapologetic bet on privacy. In a space full of token-hopping and hype-chasing, this kind of clarity is refreshing. And let’s be honest. With governments watching digital money more closely than ever, a play for privacy isn’t just bold. It’s necessary. Whether they reach 5% Zcash ownership or not, they’ve already made a statement that few others in the industry are willing to commit to.
